These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 11425884)
61. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis. Hammer LA; Waldner H; Zagon IS; McLaughlin PJ Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376 [TBL] [Abstract][Full Text] [Related]
62. Standardizing optic nerve crushes with an aneurysm clip. Feng DF; Chen ET; Li XY; Liu Y; Wang Y Neurol Res; 2010 Jun; 32(5):476-81. PubMed ID: 20021737 [TBL] [Abstract][Full Text] [Related]
64. The role of dendritic cells in CNS autoimmunity. Zozulya AL; Clarkson BD; Ortler S; Fabry Z; Wiendl H J Mol Med (Berl); 2010 Jun; 88(6):535-44. PubMed ID: 20217033 [TBL] [Abstract][Full Text] [Related]
65. T cell-based therapeutic vaccination for spinal cord injury. Schwartz M; Hauben E Prog Brain Res; 2002; 137():401-6. PubMed ID: 12440382 [TBL] [Abstract][Full Text] [Related]
66. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123 [TBL] [Abstract][Full Text] [Related]
67. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. Jones TB; Basso DM; Sodhi A; Pan JZ; Hart RP; MacCallum RC; Lee S; Whitacre CC; Popovich PG J Neurosci; 2002 Apr; 22(7):2690-700. PubMed ID: 11923434 [TBL] [Abstract][Full Text] [Related]
68. Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation. Veremeyko T; Yung AWY; Dukhinova M; Kuznetsova IS; Pomytkin I; Lyundup A; Strekalova T; Barteneva NS; Ponomarev ED Front Immunol; 2018; 9():50. PubMed ID: 29422898 [TBL] [Abstract][Full Text] [Related]
69. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination. Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067 [TBL] [Abstract][Full Text] [Related]
70. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Karnezis T; Mandemakers W; McQualter JL; Zheng B; Ho PP; Jordan KA; Murray BM; Barres B; Tessier-Lavigne M; Bernard CC Nat Neurosci; 2004 Jul; 7(7):736-44. PubMed ID: 15184901 [TBL] [Abstract][Full Text] [Related]
72. Regenerative Responses and Axon Pathfinding of Retinal Ganglion Cells in Chronically Injured Mice. Yungher BJ; Ribeiro M; Park KK Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1743-1750. PubMed ID: 28324115 [TBL] [Abstract][Full Text] [Related]
73. Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells. Tabi Z; McCombe PA; Pender MP Eur J Immunol; 1994 Nov; 24(11):2609-17. PubMed ID: 7957554 [TBL] [Abstract][Full Text] [Related]
74. Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses. Yin LL; Lin LL; Zhang L; Li L Neuropharmacology; 2012 Oct; 63(5):851-62. PubMed ID: 22728315 [TBL] [Abstract][Full Text] [Related]
75. Model of acute injury to study neuroprotection. Schwartz M; Kipnis J Methods Mol Biol; 2007; 399():41-53. PubMed ID: 18309924 [TBL] [Abstract][Full Text] [Related]
76. CD24 on the resident cells of the central nervous system enhances experimental autoimmune encephalomyelitis. Liu JQ; Carl JW; Joshi PS; RayChaudhury A; Pu XA; Shi FD; Bai XF J Immunol; 2007 May; 178(10):6227-35. PubMed ID: 17475850 [TBL] [Abstract][Full Text] [Related]
77. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells. Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391 [TBL] [Abstract][Full Text] [Related]
78. High interleukin-10 expression within the central nervous system may be important for initiation of recovery of Dark Agouti rats from experimental autoimmune encephalomyelitis. Blaževski J; Petković F; Momčilović M; Jevtic B; Miljković D; Mostarica Stojković M Immunobiology; 2013 Sep; 218(9):1192-9. PubMed ID: 23664544 [TBL] [Abstract][Full Text] [Related]
79. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510 [TBL] [Abstract][Full Text] [Related]
80. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]